CC Stock: Price, Earnings History and SEC Filings
The Chemours Company (CC) last traded at $13.53, up 2.58% on the latest session and down 0.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.42 against an analyst estimate of $0.43, a miss of 2.3%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CC earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $0.42 | $0.43 | -2.33% |
| Mar 2026 | May 5, 2026 | $0.05 | $-0.05 | +200.00% |
| Sep 2025 | Nov 6, 2025 | $0.20 | $0.24 | -16.67% |
CC beat the analyst EPS estimate in 1 of its last 3 reported quarters. Source: Nasdaq.
How CC reacts to earnings
Across its last 8 earnings releases, CC moved 11.4% on average the next session, in either direction. It rose after 3 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-04 | After close | -18.63% |
| 2026-05-05 | After close | -15.28% |
| 2026-02-19 | After close | -16.51% |
| 2025-11-06 | After close | +6.56% |
| 2025-08-05 | After close | -4.99% |
| 2025-05-06 | After close | -9.92% |
| 2025-02-18 | Before open | +3.86% |
| 2024-11-04 | Before open | +15.49% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
CC financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $5.8B | -$386M | $51M | -6.6% | $-2.57 |
| 2024 | $5.8B | $69M | -$993M | 1.2% | $0.46 |
| 2023 | $6.1B | -$253M | $186M | -4.2% | $-1.70 |
| 2022 | $6.8B | $578M | $448M | 8.5% | $3.65 |
| 2021 | $6.3B | $608M | $537M | 9.6% | $3.60 |
| 2020 | $5.0B | $219M | $540M | 4.4% | $1.32 |
| 2019 | $5.5B | -$52M | $169M | -0.9% | $-0.32 |
| 2018 | $6.6B | $995M | $642M | 15.0% | $5.45 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for CC
- 8-K · Sep 10, 2026Material agreement, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Sep 9, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Aug 5, 2026
- 8-K · Aug 4, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 24, 2026Material agreement, Regulation FD disclosure, Financial statements and exhibits
- 10-Q · May 5, 2026
- 8-K · May 5, 2026Results of operations, Financial statements and exhibits
- 8-K · Apr 30, 2026Officer or director change, Shareholder vote, Financial statements and exhibits
- 8-K · Mar 12, 2026Material agreement, New financial obligation, Other events
- DEF 14A · Mar 10, 2026
Insider filing activity
CC insiders filed 14 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
CC news
- Chemours CompanyOct 30, 2026 · 247wallst.com
- Canton Strategic Holdings Plans Tokenized Trading of Its Own Shares on Canton NetworkOct 29, 2026 · cryptoprowl.com
- Chemours Announces Fourth Quarter DividendOct 27, 2026 · finance.yahoo.com
- Chemours Announces Dates for Third Quarter 2026 Earnings Release and Webcast Conference CallOct 21, 2026 · finance.yahoo.com
- How Patent Battles At Chemours (CC) Have Changed Its Investment StoryOct 21, 2026 · finance.yahoo.com
- Chemours and Local Officials Take Action to Protect Refrigerant Intellectual Property at ChillventaOct 19, 2026 · finance.yahoo.com
About The Chemours Company
The Chemours Company (CC) is a US-listed public company on NYSE. The SEC classifies its business as Chemicals & Allied Products. It is incorporated in DE. Its fiscal year ends in December.